Liver macrophages in health and disease
M Guilliams, CL Scott - Immunity, 2022 - cell.com
Single-cell and spatial transcriptomic technologies have revealed an underappreciated
heterogeneity of liver macrophages. This has led us to rethink the involvement of …
heterogeneity of liver macrophages. This has led us to rethink the involvement of …
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
RNA therapeutics show a significant breakthrough for the treatment of otherwise incurable
diseases and genetic disorders by regulating disease-related gene expression. The …
diseases and genetic disorders by regulating disease-related gene expression. The …
Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies
I Lurje, NT Gaisa, R Weiskirchen, F Tacke - Molecular Aspects of Medicine, 2023 - Elsevier
Fibrosis, or tissue scarring, develops as a pathological deviation from the physiological
wound healing response and can occur in various organs such as the heart, lung, liver …
wound healing response and can occur in various organs such as the heart, lung, liver …
Understanding nanomaterial–liver interactions to facilitate the development of safer nanoapplications
Nanomaterials (NMs) are widely used in commercial and medical products, such as
cosmetics, vaccines, and drug carriers. Exposure to NMs via various routes such as dermal …
cosmetics, vaccines, and drug carriers. Exposure to NMs via various routes such as dermal …
Oxidative stress in liver pathophysiology and disease
The liver is an organ that is particularly exposed to reactive oxygen species (ROS), which
not only arise during metabolic functions but also during the biotransformation of …
not only arise during metabolic functions but also during the biotransformation of …
Tumor microenvironment of hepatocellular carcinoma: challenges and opportunities for new treatment options
Z Sas, E Cendrowicz, I Weinhäuser… - International Journal of …, 2022 - mdpi.com
The prevalence of liver cancer is constantly rising, with increasing incidence and mortality in
Europe and the USA in recent decades. Among the different subtypes of liver cancers …
Europe and the USA in recent decades. Among the different subtypes of liver cancers …
Near-infrared-II photoacoustic imaging and photo-triggered synergistic treatment of thrombosis via fibrin-specific homopolymer nanoparticles
J Song, X Kang, L Wang, D Ding, D Kong, W Li… - Nature …, 2023 - nature.com
The formation of an occlusive thrombus in the blood vessel is the main culprit for numerous
life-threatening cardiovascular diseases that represent the leading cause of morbidity and …
life-threatening cardiovascular diseases that represent the leading cause of morbidity and …
Use of a liver-targeting immune-tolerogenic mRNA lipid nanoparticle platform to treat peanut-induced anaphylaxis by single-and multiple-epitope nucleotide …
While oral desensitization is capable of alleviating peanut allergen anaphylaxis, long-term
immune tolerance is the sought-after goal. We developed a liver-targeting lipid nanoparticle …
immune tolerance is the sought-after goal. We developed a liver-targeting lipid nanoparticle …
[HTML][HTML] Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease
Z Boyer-Diaz, P Aristu-Zabalza, M Andrés-Rozas… - Journal of …, 2021 - Elsevier
Background & aims In advanced chronic liver disease (ACLD), deregulated hepatic
necroinflammatory processes play a key role in the development of liver microvascular …
necroinflammatory processes play a key role in the development of liver microvascular …
Targeting FAPα-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models
M Qi, S Fan, M Huang, J Pan, Y Li… - The Journal of …, 2023 - Am Soc Clin Investig
Vessel co-option has been demonstrated to mediate colorectal cancer liver metastasis
(CRCLM) resistance to antiangiogenic therapy. The current mechanisms underlying vessel …
(CRCLM) resistance to antiangiogenic therapy. The current mechanisms underlying vessel …